Range
31.45 - 32.78
Vol / Avg.
370.7K/1.8M
Div / Yield
-
52 Wk
12.8 - 50.54
Mkt Cap
1.5B
Payout Ratio
-
Open
32.01
P/E
-
EPS
-0.69
Shares
47.6M
Outstanding
47.6M
Total Float
38.1M
load more
Sector: Health Care.Industry: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.510-0.690 -0.1800
REV7.310M2.265M-5.045M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Protagonist Therapeutics Questions & Anwsers

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Protagonist Therapeutics's (PTGX) competitors?

Q

What is the target price for Protagonist Therapeutics (PTGX) stock?

A

The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by JMP Securities on October 13, 2021. The analyst firm set a price target for 60.00 expecting PTGX to rise to within 12 months (a possible 85.07% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $32.42 last updated Tue Oct 26 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A

Protagonist Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.

Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.